XML 24 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Investments:    
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $293,130 and $286,816, respectively) $ 326,049 $ 298,265
Equity securities, at estimated fair value 1,341 1,440
Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes $3 and $4, respectively, relating to variable interest entities) 12,671 12,616
Mortgage loans (net of valuation allowances of $350 and $342, respectively; includes $218 and $299, respectively, under the fair value option) 78,959 75,752
Policy loans 9,671 9,699
Real estate and real estate joint ventures (includes $250 and $0, respectively, of real estate held-for-sale) 10,246 9,698
Other limited partnership interests 7,441 6,613
Short-term investments, principally at estimated fair value 3,536 3,937
Other invested assets (includes $2,352 and $2,300, respectively, of leveraged and direct financing leases and $258 and $141, respectively, relating to variable interest entities) 21,979 18,190
Total investments 471,893 436,210
Cash and cash equivalents, principally at estimated fair value (includes $15 and $52, respectively, relating to variable interest entities) 19,452 15,821
Accrued investment income 3,561 3,582
Premiums, reinsurance and other receivables (includes $5 and $3, respectively, relating to variable interest entities) 20,723 19,644
Deferred policy acquisition costs and value of business acquired 17,382 18,895
Goodwill 9,278 9,422
Other assets (includes $2 and $2, respectively, relating to variable interest entities) 10,166 8,408
Separate account assets 190,357 175,556
Total assets 742,812 687,538
Liabilities    
Future policy benefits 193,310 186,780
Policyholder account balances 189,060 183,693
Other policy-related balances 16,960 16,529
Policyholder dividends payable 692 677
Policyholder dividend obligation 2,370 428
Payables for collateral under securities loaned and other transactions 28,443 24,794
Short-term debt 142 268
Long-term debt (includes $5 and $5, respectively, at estimated fair value, relating to variable interest entities) 13,443 12,829
Collateral financing arrangement 1,013 1,060
Junior subordinated debt securities 3,149 3,147
Current income tax payable 31 441
Deferred income tax liability 10,153 5,414
Other liabilities (includes $1 and $1, respectively, relating to variable interest entities) 25,070 22,964
Separate account liabilities 190,357 175,556
Total liabilities 674,193 634,580
Contingencies, Commitments and Guarantees (Note 16)
MetLife, Inc.’s stockholders’ equity:    
Preferred stock, par value $0.01 per share; $3,405 aggregate liquidation preference 0 0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,176,847,734 and 1,171,824,242 shares issued, respectively; 919,601,779 and 958,613,542 shares outstanding, respectively 12 12
Additional paid-in capital 32,639 32,474
Retained earnings 32,948 28,926
Treasury stock, at cost; 257,245,955 and 213,210,700 shares, respectively (12,428) (10,393)
Accumulated other comprehensive income (loss) 15,197 1,722
Total MetLife, Inc.’s stockholders’ equity 68,368 52,741
Noncontrolling interests 251 217
Total equity 68,619 52,958
Total liabilities and equity $ 742,812 $ 687,538